TrialJournal of diabetes research2025

First-Time Usage of SGLT2 Inhibitors in Patients With Type 2 Diabetes Who Are Fasting Ramadan: Efficacy and Safety.

Hany Ahmed Muhammed Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.